Cerebellar hemorrhage (CH) has a higher early mortality rate compared with other types of intracranial hemorrhage and the survivors often suffer from momentous disability. Hence, the prognostic factors of long-term outcome beyond 6 months after CH are clinically valuable, however only three studies were reported in the literature. Sixty-one patients with CH were retrospectively analyzed at least 6 months after hemorrhage. The long-term outcome of all patients and long-term functional status of survivors beyond 6 months (the patients who died within 6 months after hemorrhage were excluded) were assessed using the modified Rankin Scale (mRS): favorable outcome (mRS 0 -2) and unfavorable outcome (mRS 3 -6). All of the prognostic factors were analyzed by univariate and multivariate Cox proportional hazards regression models. There were 16 (26.2%) patients in the favorable outcome group and 45 (73.8%) in the unfavorable outcome group with respect of long-term outcome in all patients. The radiological brainstem compression (HR = 3; p = 0.015) was shown to be an independent predictor. On the other hand, 46 out of 61 (75.4%) patients survived beyond 6 months. In total, 16 (34.7%) patients had a favorable functional status, and 65.3% (30/46) had a persistent unfavorable functional status. Moreover, only age ≥65 years (HR = 3; p = 0.019) was an independent predictor. Radiological brainstem compression and age ≥65 were respectively shown to be a strong prognostic factor for long-term outcome and functional status among survivors beyond 6 months after hemorrhage in patients with CH.
Introduction
Cerebellar hemorrhage (CH) is the least common type of intracranial hemorrhage (ICH), accounting for only 10% of all ICH cases in western countries [1] , rising to 20% -30% in the Taiwanese population [2] , due to the higher prevalence of hypertension, which is reported to be a major risk of CH [3] [4] . CH is regarded as a predictive factor of outcome following ICH because of the high risk of brainstem compression [4] . As well as a higher early mortality rate (20% to 75%) compared with other types of ICH (30% -50%) [1] [3] , survivors of the acute phase of CH often suffer from momentous disability [3] [5] . In previous studies of patients with CH, the clinical outcome was mostly assessed at hospital discharge, or within 3 months of hemorrhage [3] [5] , with only three studies assessing outcomes beyond 6 months [6] - [8] . The lack of statistics regarding long-term outcomes in patients with CH hinders therapeutic decision making for survivors at the sub-acute and chronic stages. The purpose of this study was to survey the significant prognostic factors of this topic, and review the existing literature.
Materials and Methods
Sixty-one patients diagnosed with acute spontaneous CH, without prior disability, were admitted to our hospital between 2004 and 2011, within 48 h of the onset of symptoms. None of the patients had suffered a prior stroke, or presented with complications associated with another hemorrhagic lesion or hemorrhagic transformation of ischemic stroke. On admission, all patients underwent detailed physical examination, routine laboratory testing, and imaging studies. The initial neurological state of all patients was evaluated using the Glasgow coma scale (GCS). Patients' blood glucose/sugar (BS), systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR), and body temperature (BT) were measured immediately before they underwent computerized tomography. Basic characteristics, including age, gender, date of birth, and pre-existing or concomitant illnesses, were collected. Imaging findings, including the maximum diameter of hematoma, evidence of intraventricular hemorrhage (IVH), radiographic signs of brainstem compression (presence of obliterated basal cisterns), and hydrocephalus, were also obtained. Surgical decompression consisting of craniotomy, evacuation of hematoma, or ventricular drainage was performed (except for patients who had a large hemorrhage, or coma status without brainstem reflexes, due to its predictably poor outcome) [5] [9] .
All the above information was acquired by the retrospective analysis of patient charts. Clinical data concerning long-term outcomes and functional status during the follow-up period were retrieved from medical records, or from a telephone interview with the patient, close relatives, or caregiver, conducted by the same physician. The long-term outcome and functional status were assessed using the modified Rankin Scale (mRS) [10] . The follow-up time was at least 6 months after hemorrhage, and endpoints were calculated from the onset of CH until data capture.
All patients were divided into 2 outcome groups: favorable outcome (mRS scale 0 -2) and unfavorable outcome (mRS scale 3 -6). The cut-off points of continuous variables were based on previously published cut-off values: age ≥65 [11] , BS levels ≥140 mg/dl [4] [12] , maximum hematoma diameter ≥3 cm [4] [13] , SBP ≥200 mmHg [4] [13] , GCS scores ≤8 [4] [14] , HR ≥100 beats/min [13] , BT ≥37.5˚C [4] [15] , and DBP ≥120 mmHg [4] [16] . Variables showing p < 0.05 in the univariate analysis were incorporated into the multivariate analysis, which was performed using the enter regression method. The independent risk factors in the final model were presented as hazard ratios (HRs) with 95% confidence intervals (CIs). The threshold for statistical significance was set at p < 0.05.
Results: Long-term outcome: Follow-up evaluation was completed for all 61 patients, and the mean follow-up time was 38.3 ± 30.8 months. The baseline characteristics of the study population are summarized in Table 1 . The mean age of patients was 65.5 ± 15.8 years (standard deviation). In total, there were 16 (26.2%) patients in the favorable outcome group (11 men, 5 women), and 45 (73.8%) in the unfavorable outcome group (28 men, 17 women). The results from the univariate and multivariate enter Cox regression analyses for longterm outcome are shown in Table 2 . The following 4 risk factors were found to be significantly correlated with long-term outcome in the univariate analysis: GCS scores ≤ 8 (HR = 3.4; p < 0.001), initial BS levels ≥ 140 mg/dl (HR = 2.8; p = 0.002), maximum hematoma diameter ≥ 3 cm (HR = 3.2; p = 0.001), radiological brainstem compression (HR = 6.1; p < 0.001).
Long-term functional status of survivors: Of these 61 patients, 15 patients (24.6%) died during hospitalization, and 46 patients (75.4%) survived after discharge. No patients died during the follow-up period of at least 6 months after hemorrhage. In total, 16 out of 46 patients (34.7%) had a favorable functional status, and 65.3% Table 1 . The baseline characteristics of the study population affecting long-term functional status in all patients and survivors at least 6 months after hemorrhage. Note: GCS = Glasgow Coma Scale, SBP = systolic blood pressure, DBP = diastolic blood pressure, HR = heart rate, BT = body temperature, BS = blood glucose/sugar, IVH = intraventricular hemorrhage Variables associated with p value < 0.05 on univariate analysis were incorporated in the multivariate analysis which was performed by enter Cox regression model. The independent risk factors in the final model were presented as hazard ratios, including 95% confidence intervals (CI).
(30/46) had a persistent unfavorable functional status at the 6-month follow up. 
Discussion
Our study showed that radiological brainstem compression (HR = 3) was a strong predictor of long-term outcome at least 6 months after hemorrhage in patients with CH. Moreover, an age ≥65 years was the single independent predictor (HR = 3) of long-term functional status in survivors beyond 6 months after CH. To the best of our knowledge, this is the first study of this topic in Taiwanese population. Only three studies have been published concerning the predictors of long-term outcome and functional status more than 6 months after CH [6] - [8] . Dolderer et al. [6] followed 75 patients with CH (mean follow up period, 49 ± 34 months) and found that only 32% achieved a favorable outcome (mRS 0 -2). The unfavorable outcome group (68%) had a mortality rate of 48% (36 out of 75 patients), and 61.5% of survivors (24/39) achieved a favorable outcome. They revealed that factors associated with unfavorable long-term outcome were decreased consciousness level, clinical signs of brainstem compression, hydrocephalus, intubation, and surgical intervention. Dammann and colleagues [7] followed 57 surgically treated patients with CH for at least 12 months (mean follow-up time, 34 months). In total, 27 out of 57 patients (47.3%) had a favorable outcome, defined according to the Glasgow outcome scale (4 -5); 16 patients (27.7%) had a persistent unfavorable functional outcome, and 14 patients died (25%). Of the survivors, 62.7% achieved a favorable outcome. The initial neurological condition, level of consciousness, radiological brainstem compression, and a tight posterior fossa were predictive of long-term poor clinical outcome. Pong et al. [8] followed 72 Chinese patients with CH, of which 12 patients died within 30 days (16.7%), 26 (36.1%) achieved a favorable functional status, and 47.2% had an unfavorable functional status. 43.3% of survivors had reached a favorable outcome at 6 months after CH. After excluding patients dying within 30 days, age ≥75 was shown to be an independent predictor of functional status at 6 months. The results of the current study are in accordance with these previous findings.
Brainstem compression by cerebellar hematoma is a specific and severe complication of CH as compared with other types of ICH, and may contribute significantly to neurological deterioration, impaired consciousness, and death [17] . Notably, the mortality rate was highest within the first 3 months after CH, so it is not surprising that radiological brainstem compression was a strong prognostic factor for long-term outcome in the present study. Indeed, radiological brainstem compression was also found to be predictive of first-week mortality [18] , Note: 1. GCS = Glasgow Coma Scale, SBP = systolic blood pressure, DBP = diastolic blood pressure, HR = heart rate, BT = body temperature, BS = blood glucose/sugar, IVH = intraventricular hemorrhage 2. Variables associated with p value < 0.05 on univariate analysis were incorporated in the multivariate analysis which was performed by enter Cox regression model. The independent risk factors in the final model were presented as hazard ratios, including 95% confidence intervals (CI). 3.
short-term neurological deterioration, and poor outcome [13] . Several retrospective studies have analyzed the clinical and imaging features associated with, or predictive of, poor outcome at discharge or within 3 months of CH: increased hematoma size was strongly correlated with poor outcome [4] [5]; GCS ≤8 was a significant predictor of death [8] [14] [18]; a maximum hematoma diameter ≥3 cm was predictive of neurological deterioration and poor outcome [4] [13] [14] . The imaging features indicative of a poor prognosis were the presence of IVH [4] [6], hydrocephalus [4] [19] , and visible brainstem compression [4] [6] [7] [18] . Moreover, when patients dying in the acute stage of CH were excluded, age become the only prognostic factor of long-term functional status, both in our study, and in recent research [8] .
Conclusion
In conclusion, radiological brainstem compression was shown to be a strong prognostic factor for long-term Note: 1. GCS = Glasgow Coma Scale, SBP = systolic blood pressure, DBP = diastolic blood pressure, HR = heart rate, BT = body temperature, BS = blood glucose/sugar, IVH = intraventricular hemorrhage 2. Variables associated with p value < 0.05 on univariate analysis were incorporated in the multivariate analysis which was performed by enter Cox regression model. The independent risk factors in the final model were presented as hazard ratios, including 95% confidence intervals (CI). 3. outcome after at least 6 months in patients with CH. On the other hand, an age ≥65 was an independent prognostic factor of long-term functional status among survivors beyond 6 months after hemorrhage. These findings may facilitate the identification of prognostic factors for long-term outcome after CH, thereby aiding clinicians and patients in selecting treatment and management strategies.
